341205 Sigma-AldrichEtoposide - CAS 33419-42-0 - Calbiochem
Etoposide, CAS 33419-42-0, is cell-permeable inhibitor of topoisomerase II inhibitor (IC50 = 59.2 µM). Displays anti-tumor activity.
More>> Etoposide, CAS 33419-42-0, is cell-permeable inhibitor of topoisomerase II inhibitor (IC50 = 59.2 µM). Displays anti-tumor activity. Less<<同義語: VP-16
お勧めの製品
概要
Replacement Information |
---|
主要スペック表
CAS # | Empirical Formula |
---|---|
33419-42-0 | C₂₉H₃₂O₁₃ |
価格&在庫状況
カタログ番号 | 在庫状況 | 包装 | Qty/Pk | 価格 | 数量 | |
---|---|---|---|---|---|---|
341205-25MGCN |
|
樹脂アンプル | 25 mg |
|
— |
Product Information | |
---|---|
CAS number | 33419-42-0 |
ATP Competitive | N |
Form | White solid |
Hill Formula | C₂₉H₃₂O₁₃ |
Chemical formula | C₂₉H₃₂O₁₃ |
Reversible | N |
Structure formula Image | |
Quality Level | MQ100 |
Applications | |
---|---|
Application | Etoposide, CAS 33419-42-0, is cell-permeable inhibitor of topoisomerase II inhibitor (IC50 = 59.2 µM). Displays anti-tumor activity. |
Biological Information | |
---|---|
Primary Target | topoisomerase 2 |
Primary Target IC<sub>50</sub> | 59.2 µM inhibiting topoisomerase II |
Purity | >95% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | Y |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS | |
---|---|
RTECS | KC0190000 |
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
カタログ番号 | GTIN |
341205-25MGCN | 04055977215434 |
Documentation
Etoposide - CAS 33419-42-0 - Calbiochem (M)SDS
タイトル |
---|
Etoposide - CAS 33419-42-0 - Calbiochem 試験成績書(CoA)
タイトル | ロット番号 |
---|---|
341205 |
参考資料
参考資料の概要 |
---|
De Lange, A.M., et al. 1995. J. Virol. 69, 2082. Kaufman, S.H., et al. 1993. Cancer Res. 53, 3976. Onishi, Y., et al. 1993. Biochim. Biophys. Acta 1175, 147. Terada, T., et al. 1993. J. Med. Chem. 36, 1689. Wazniak, A.J., et al. 1991. J. Clin. Oncol. 9, 70. Einhorn, L.H., et al. 1988. J. Clin. Oncol. 6, 451. Issel, B.F. 1982. Cancer Chemother. Pharmacol. 7, 73. |